Montalescot G - Search Results

1

Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial.

Beygui F, Vicaut E, Ecollan P, Machecourt J, Van Belle E, Zannad F, Montalescot G. Beygui F, et al. Among authors: montalescot g. Am Heart J. 2010 Oct;160(4):642-8. doi: 10.1016/j.ahj.2010.06.049. Am Heart J. 2010. PMID: 20934557 Clinical Trial.

2

Coronary blood flow reserve measured by contrast media injection depends on myocardial viability.

Drobinski G, Montalescot G, Moussallem N, Canny M, Grosgogeat Y. Drobinski G, et al. Among authors: montalescot g. Eur Heart J. 1991 Jan;12(1):44-9. doi: 10.1093/oxfordjournals.eurheartj.a059823. Eur Heart J. 1991. PMID: 2009892

3

Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteries.

Montalescot G, Drobinski G, Maclouf J, Lellouche F, Ankri A, Moussallem N, Eugene L, Thomas D, Grosgogeat Y. Montalescot G, et al. Am Heart J. 1990 Dec;120(6 Pt 1):1445-7. doi: 10.1016/0002-8703(90)90261-u. Am Heart J. 1990. PMID: 2248190 No abstract available.

4

Clinical and ultrasound results after aortic valve replacement: intermediate-term follow-up with the St. Jude Medical prosthesis.

Montalescot G, Thomas D, Drobinski G, Evans JI, Vicaut E, Chatellier G, Whyte RI, Busquet P, Bejean-Lebuisson A, Grosgogeat Y. Montalescot G, et al. Am Heart J. 1989 Jul;118(1):104-13. doi: 10.1016/0002-8703(89)90079-3. Am Heart J. 1989. PMID: 2741777

5

Arteriolar vasoconstriction and tachyphylaxis with intraarterial angiotensin II.

Vicaut E, Montalescot G, Hou X, Stucker O, Teisseire B. Vicaut E, et al. Among authors: montalescot g. Microvasc Res. 1989 Jan;37(1):28-41. doi: 10.1016/0026-2862(89)90070-8. Microvasc Res. 1989. PMID: 2921948

6

Fibrinogen after coronary angioplasty as a risk factor for restenosis.

Montalescot G, Ankri A, Vicaut E, Drobinski G, Grosgogeat Y, Thomas D. Montalescot G, et al. Circulation. 1995 Jul 1;92(1):31-8. doi: 10.1161/01.cir.92.1.31. Circulation. 1995. PMID: 7788913

7

Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.

Montalescot G, Philippe F, Ankri A, Vicaut E, Bearez E, Poulard JE, Carrie D, Flammang D, Dutoit A, Carayon A, Jardel C, Chevrot M, Bastard JP, Bigonzi F, Thomas D. Montalescot G, et al. Circulation. 1998 Jul 28;98(4):294-9. doi: 10.1161/01.cir.98.4.294. Circulation. 1998. PMID: 9711933 Clinical Trial.

8

Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.

Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F, Choussat R, Morin E, Thomas D. Montalescot G, et al. Am J Cardiol. 1998 Sep 15;82(6):749-55. doi: 10.1016/s0002-9149(98)00439-1. Am J Cardiol. 1998. PMID: 9761085

9

IIb/IIIa inhibitors in acute myocardial infarction.

Montalescot G. Montalescot G. Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S71-5. Blood Coagul Fibrinolysis. 1999. PMID: 10070824 Review.

10

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.

Montalescot G, Collet JP, Lison L, Choussat R, Ankri A, Vicaut E, Perlemuter K, Philippe F, Drobinski G, Thomas D. Montalescot G, et al. J Am Coll Cardiol. 2000 Jul;36(1):110-4. doi: 10.1016/s0735-1097(00)00695-1. J Am Coll Cardiol. 2000. PMID: 10898421 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

813 results

Search Page

Filters